PEOPLE - Bio-Vascular (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Bio-Vascular has appointed Nicholas Oray of Seatrace Pharmaceuticals vice-president of research and development. The US company manufactures medical products for use in thoracic, cardiac, neuro, ophthalmic and vascular surgery.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.